It showed a staggering 63,060 percent surge in excess deaths among children aged zero to 14 by the 22nd week of 2023 from when the vaccine had been given emergency use authorization (EUA) by drug regulator European Medicines Agency (EMA). The data covers 26 out of the 44 countries in Europe.
A report by independent news outlet Expose provided a chart that covered the period from January 3 to March 27, 2022, and concluded a total number of SARS-CoV-2 cases categorized by vaccination status and age group in England. "The data, extracted from the U.K. Health Security Agency (UKHSA) Week 5, (page 43), Week 9 (page 41) and Week 13 (page 41) COVID-19 Vaccine Surveillance report painted a vivid picture of the disconcerting reality," reported Expose.
Another revealing chart indicated the case rates per 100,000 people, also segregated by vaccination status and age group in the country. The chart showed an alarming disparity, with case rates skyrocketing among the triple-vaccinated population in every age group.
During week 21 of 2021, EMA extended the EUA of Pfizer's COVID-19 vaccine, first to children aged 12 to 15 and later to the five to 11 age group. From then on, a shocking rise in excess deaths among children was observed. Between weeks 22 and 52 of 2021, there was a startling tally of 919 excess deaths among children aged zero to 14 compared to week 1 to week 21, which saw 218 fewer deaths than expected.
The unfortunate trend continued throughout 2022, with a total of 1,639 excess deaths among children aged zero to 14 across the 26 European countries. Since the EMA extended the EUA of Pfizer's COVID-19 vaccine to children, 3,148 excess deaths among children have been recorded across the continent. (Related: European children suffer appalling 755% increase in excess death after COVID VACCINE approval.)
Messenger RNA jabs leave the inoculated more vulnerable to the virus
The independent media outlet also pointed out why messenger RNA (mRNA) vaccines like Pfizer's were not widely employed in the general population until December 2020. It was because of the fear of antibody-dependent enhancement (ADE), which is an occurrence where mRNA vaccines potentially exacerbate the disease, rendering the vaccinated to be more susceptible to the disease.
"History had already witnessed a chilling episode of ADE during the development of a dengue fever vaccine. Initial trials indicated promise, displaying protection against the virus for those unscathed by prior infections," the Expose article noted. "Sadly, in individuals who had encountered a different strain of the virus before, the vaccine seemed to amplify the risk of severe illness, a grim testament to the treacherous nature of ADE."
Numerous studies done on animals indicated that the shots caused lung inflammation and other adverse effects. Also, the Vaccine-Associated Enhanced Disease (VAED) specter loomed large during respiratory virus vaccine trials, including those against coronaviruses.
Meanwhile, the SARS-CoV-2 virus appeared to spare the younger generation, raising perplexing questions about the extension of EUA for mRNA vaccinations to children. Critics wondered from then on why health authorities needed to extend the EUA when there is no imminent threat to children.
"The ultimate goal couldn't have been containment, as real-world data revealed an ironic twist: the COVID-19 vaccinated population seemed to exhibit a higher likelihood of infection and transmission compared to their unvaccinated counterparts. The very shield intended to protect against the virus appeared to falter in its mission," the Expose article pointed out.
Follow VaccineDeaths.com for more news about how the experimental vaccines killed people, young and old, worldwide.
Watch the video below that talks about the massive vaccine death rate from the fully vaccinated population.
This video is from Katy Odin's channel on Brighteon.com.
More related stories:
Study finds possible link between Pfizer's COVID-19 vaccine and myocarditis in children.
Excess deaths among children in Europe soar following vaccine rollout for younger age groups.
Sources include:
Please contact us for more information.
